ANVS Jan 2025 2.500 put
| Previous Close | 0.8300 |
| Open | 0.8200 |
| Bid | 0.8000 |
| Ask | 0.9500 |
| Strike | 2.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.8200 - 0.9500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 149 |
GlobeNewswireAnnovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
MALVERN, Pa., June 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap. Investor Call Details: Date and Time: July 2, 2024, 4:30pm ET.Re
- GlobeNewswire
Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD), is pleased to announce that it has been selected to present the data from its latest Alzheimer’s study in an extended 45-minute session at the Alzheimer’s Association International Conference® 2024 (AAIC®). The conference will take p
GlobeNewswireAnnovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
Join Our Investor Call for In-Depth Findings Discussion Efficacy in Early AD Patients Buntanetap showed statistically significant efficacy and safety in both carriers and non-carriers of Apolipoprotein E4 (APOE4), a genetic cause of AD. Comparable Safety Buntanetap was found to be equally safe in both APOE4 carriers and non-carriers, with no instances of ARIA. MALVERN, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug p
